Clinical Trials Directory

Trials / Completed

CompletedNCT04180462

Increasing Optimal Use of HPV Vaccination in Primary Care

Randomized Controlled Trial to Evaluate an Implementation Strategy to Increase Optimal Use of HPV Vaccine in Primary Care

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

Washington University will evaluate the effectiveness of a multi-component implementation strategy to increase use of HPV vaccine in primary care practices.

Detailed description

The investigators at Washington University will complete a cluster-randomized trial to evaluate the effectiveness of a multi-component implementation strategy (the intervention) to increase use of the HPV vaccine according to CDC guidelines. The unit of randomization is a community-based, primary care pediatric practice. Twenty practices will be randomized into two groups, the intervention group (n=10) or a wait-list control group (n=10). The intervention will be implemented over 2-years and includes: 1) an educational video for providers; 2) audit and feedback of vaccine coverage; 3) a communication strategy; and 4) practice facilitation. The primary outcome of HPV vaccination by age 13 will be assessed at 24 months, and at 36 months to assess if change is sustained.

Conditions

Interventions

TypeNameDescription
OTHERPractice FacilitationPractice facilitation to support quality improvement methods to effect practice change to develop a sustainable HPV vaccine delivery system.
OTHEREducationAn educational video to increase the provider's knowledge about guideline recommendations and patient and practice benefits of vaccination by age 13.
OTHERAudit and FeedbackAudit and feedback of vaccine coverage to increase motivation to engage in practice change.
OTHERCommunication StrategyA communication strategy to improve the provider's communication skills and their self-efficacy to address parental hesitation.

Timeline

Start date
2020-01-07
Primary completion
2023-02-14
Completion
2024-04-29
First posted
2019-11-27
Last updated
2025-03-25
Results posted
2024-02-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04180462. Inclusion in this directory is not an endorsement.